Personalised Medicine / Miro Venturi - CEO, Sintetica
Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey,…
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by Bayer, Janssen and Mylan. French…
Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey,…
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
CEO Tero Silvola introduces BC Platforms’ powerful data and technology platform for personalized medicine and…
The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
One of the largest domestic pharma companies in China (ranking number one from…
The latest China pharma news, including the upcoming first domestic approval for…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
A roundup of the latest from the Middle East & Africa region, including…
Following on from our list of the overall top 10 companies in the Saudi Arabian…
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
This article forms part of Healthcare & Life Sciences Review: Switzerland…
Although Switzerland is ahead of many of its competitors in Europe on levels of…
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands…
After an illustrious career in oncology R&D, contributing greatly to the…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed…
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
The latest UK pharma news, including how new investment in GSK stands to reshape…
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for…
Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person.…
Singapore – despite its modest USD 1.22 billion domestic market – has long…
Following on from our profile on five of the most promising clinical-stage…
The AAM’s Dan Leonard highlights the savings impact that generic and…
With Rare Disease Day coming up on February 28th, one of the leading…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
The latest China pharma news, including the upcoming first domestic approval for…
The latest from Italian pharma, including the government’s decision to make…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia,…